Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Elīna Skuja"'
Autor:
J. Maksimenko, Janis Gardovskis, Dace Bērziņa, Elīna Skuja, Genādijs Trofimovičs, Gunta Purkalne, Arvīds Irmejs, Edvins Miklasevics
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 16, Iss 1, Pp 1-7 (2018)
Background Pathogenic BRCA1 founder mutations (c.4035delA, c.5266dupC) contribute to 3.77% of all consecutive primary breast cancers and 9.9% of all consecutive primary ovarian cancers. Identifying germline pathogenic gene variants in patients with p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::882acb242aab7f97495600653f01bf1e
http://link.springer.com/article/10.1186/s13053-018-0094-0
http://link.springer.com/article/10.1186/s13053-018-0094-0
Autor:
Elīna Skuja, D Butane, Gunta Purkalne, Miki Nakazawa-Miklasevica, Edvins Miklasevics, Zanda Daneberga
Publikováno v:
Experimental oncology. 41(4)
Aim In our previously reported study, we found a correlation between DNA massive fragmentation and increased progression free survival (PFS) in metastatic colorectal cancer (mCRC), but not overall survival. The aim of this study is to find overlappin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa2315635eabbcfd8c34b3bd8e873530
https://pubmed.ncbi.nlm.nih.gov/31868331
https://pubmed.ncbi.nlm.nih.gov/31868331
Publikováno v:
Acta Chirurgica Latviensis. 12:15-19
SummaryIntroduction.Despite recent advances in the medical treatment of metastatic colorectal cancer (mCRC), which include oxaliplatinand irinotecan-based first-line regimens and the increasing use of targeted monoclonal antibodies, survival rates fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3761ac989bb396981b939e61ead32bb6
https://doi.org/10.2478/v10163-012-0003-y
https://doi.org/10.2478/v10163-012-0003-y
Autor:
Zanda Daneberga, Dagnija Kalniete, Miki Nakazawa-Miklasevica, Elīna Skuja, Edvins Miklasevics, Arnis Abolins, Gunta Purkalne
Publikováno v:
European Journal of Cancer. 69:S120-S121
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7942f66390017c697be0b2847a6de888
https://doi.org/10.1016/s0959-8049(16)32959-8
https://doi.org/10.1016/s0959-8049(16)32959-8
Autor:
Vija Bērziņa, Arturs Sorubalko, Elīna Skuja, Viktors Kozirovskis, Aija Geriņa-Bērziņa, Gunta Purkalne
Publikováno v:
Lung Cancer. 77:S34-S35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5b5e3868e1734a983cdedeb95c97b45
https://doi.org/10.1016/j.lungcan.2012.05.065
https://doi.org/10.1016/j.lungcan.2012.05.065